Nuritas Ltd. announced the appointment of former Pfizer Nutrition and Nestlé president Emmet Browne as its chief executive officer.
Nuritas has developed a proprietary technology using big data techniques to discover bioactive, natural peptides for use in the functional and medical food, personal care and nutritional supplement markets, which are currently estimated to be worth €200B.
Browne brings 25 years working in the pharmaceutical, nutrition and health care sectors, including a key role in overseeing, preparing and delivering the sale of Pfizer Nutrition to Nestlé for €11.85B in the world’s biggest health care deal of 2012.
Nuritas founder Dr. Nora Khaldi said, “We are delighted that Emmet has joined as our new CEO. His experience and leadership will be instrumental in the growth and success of Nuritas’ vision of creating healthy, sustainable, and affordable products for everyone as well as ensuring Nuritas becomes a key player on the global food stage.”
Emmet Browne said, “Nuritas is a company that brings cutting edge innovation to the nutrition industry and I am excited to be joining this expert team. It is fantastic to be part of an organization that is a world first to be using big data from food to address serious health issues. The company is unique globally in using the combination of pure mathematics, bioinformatics, and food informatics which have been brought together to revolutionize the finding of new bioactive peptides and ultimately life-changing ingredients.”
Dr. Brian O’Neill, manager of Enterprise Ireland, HPSU Industrial & Lifesciences welcomed this announcement saying, "Nuritas is a prime example of how highly innovative indigenous thinking can deliver global impact that will help drive the Irish economy of the future. Strong leadership is a proven driver of business success and Enterprise Ireland looks forward to seeing this business develop and grow on the world stage.”